Wanbury Ltd

524212

Overview

    • Equity Style Box

      Small Growth

    • Sector

      Healthcare

    • Industry

      Drug Manufacturers - Specialty & Generic

    • Day Range

      295.15 – 303.00

    • Year Range

      132.70 – 330.00

    • Market Cap

      9.7328 Bil

    • Volume / Avg

      257.0 / 15.5 k

    • Price / Sales

      1.69

    • Price / Book

      16.47

    • Price / Earnings

      33.18

    • Forward Div Yield

      0.00%

    • Trailing Div Yield

      —

Login To Show Full Chart

Summary

Fair Value Assessment
Fairly Valued
Fair ValueQ297.94UncertaintyHigh
Close Price297.95Jun 04, 2025
₹ 297.00
Price Down by 0.95 | 0.32 %
Trading Information Business Description
Previous Close
297.95
Day Range
295.15 – 303.00
Year Range
132.70 – 330.00
Bid / Ask
295.15 × 300.95
Market Cap
9.7 Bil
Volume / Average
257.0 / 15.5 k
Beta (5-Year)
–
Shares Outstanding
32.77 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Wanbury Ltd is engaged in the business of pharmaceutical and related activities including research. Some of the company products are Cpink 50mg table, Rabiplus capsules, Folinine softule, etc. The company has one segment of activity namely Pharmaceuticals. It generates revenue from a contract with customers from the sale of manufactured and traded goods. Geographically, key revenue is generated from outside India.
Contact
BSEL Techpark, B Wing 10th Floor, Sector 30-A, Navi Mumbai, MH 400703
T +91 2267942222
www.wanbury.com opens in a new tab
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Mar 31, 2025
Fiscal Year End
Mar 31, 2025
Employees
1,491
As of Mar 31, 2024

Key Metrics

Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Income Statement (in Bil, except ratios)
03/31/2025
03/2025
03/2024
03/2023
03/2022
03/2021
Revenue
6.00 6.00 5.74 4.98 5.07 3.87
Revenue Growth %
3.77% 3.77% 15.32% -1.79% 31.03% 6.76%
Gross Profit
3.05 3.05 2.65 1.90 2.01 1.65
Gross Profit Margin %
50.88% 50.88% 46.18% 38.14% 39.70% 42.64%
Operating Income
0.63 0.63 0.57 0.12 0.29 0.15
Operating Margin %
10.51% 10.51% 9.96% 2.38% 5.75% 3.81%
EBIT
0.67 0.67 0.85 0.11 1.01 0.10
EBIT Margin %
11.09% 11.09% 14.82% 2.15% 19.93% 2.65%
EBITDA
0.80 0.80 0.98 0.23 1.13 0.20
EBITDA Margin %
13.31% 13.31% 17.09% 4.63% 22.18% 5.17%
Net Income
0.31 0.31 0.56 -0.10 0.81 -0.13
Net Profit Margin %
5.09% 5.09% 9.74% -2.09% 16.06% -3.26%
Basic EPS
9.32 9.32 17.10 -3.18 25.29 -5.04
Diluted EPS
8.98 8.98 16.89 -3.18 25.21 -5.04
Normalized EPS
— — — — — —
Total Dividends per Share
— — — — — —
Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Balance Sheet (in Bil, except ratios)
03/31/2025
03/2025
03/2024
03/2023
03/2022
03/2021
Total Assets
4.14 4.14 3.43 3.04 3.53 2.89
Total Liabilities
3.55 3.55 3.16 3.37 3.76 4.45
Total Debt
1.77 1.77 1.16 1.09 1.08 2.04
Total Equity
0.59 0.59 0.28 -0.33 -0.23 -1.56
Cash And Cash Equivalents
0.04 0.04 0.03 0.01 0.23 0.10
Working Capital
0.19 0.19 -0.55 -1.96 -1.87 -2.54
Shares Outstanding (Mil)
— — 32.75 32.71 — —
Book Value Per Share
18.09 18.09 8.28 -10.53 -7.45 -62.60
Total Debt To Equity
2.98 2.98 4.17 — — —
Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Cash Flow Statement (in Bil, except ratios)
03/31/2025
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
0.26 0.04 0.20 0.41 0.17 0.44
Cash From Investing Activities
-0.51 -0.17 -0.09 0.01 0.08 0.64
Cash From Financing Activities
0.26 0.15 -0.32 -0.29 -0.17 -1.08
Capital Expenditures
0.49 0.17 0.13 0.10 0.04 0.08
Free Cash Flow
-0.07 0.20 -0.03 0.13 0.08 0.05
Change in Cash
0.01 0.02 -0.21 0.13 0.07 —

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
Oops!
Something went wrong.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
Oops!
Something went wrong.

Ownership

There is no Ownership data available.

STOCKS
MUTUAL FUNDS
ADITYABIRLAAXISBajajBANDHANBARODABNPBOICANARADSPEDELWEISSFRANKLINTEMPLETONGROWWHDFCHELIOSHSBCICICIIIFLINVESCOITIJMKOTAKLICMahindraManulifeMIRAEMOTILALNAVINipponNJOldBridgePGIMPPFASQUANTQUANTUMSAMCOSBISHRIRAMSUNDARAMTATATAURUSTrustUNIONUTIWhiteOakZERODHA
INSURANCE FUNDS
ABSLAEGONAGEASFEDERALAVIVABAJAJALLIANZBHARTIAXACANARAHSBCORIENTBANKEDELWEISSTOKIOEXIDEFUTUREGENERALIHDFCICICIPRUDENTIALINDIAFIRSTKOTAKMAHINDRALICMAXLIFEPNBMETLIFEPRAMERICARELIANCENIPPONSAHARASBISHRIRAMSTARUNIONDAI-ICHITATAAIA

About Us

Connect With Us

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top